ArticleTranslational andrology and urology2023

Presurgical immune-oncology/tyrosine kinase inhibitor combination therapy for renal cell carcinoma with a vena cava tumor thrombus: a single-institution case series.

Fumihiko Urabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.